Deflux® Endoscopic Treatment of Vesicoureteral Reflux (VUR) in Japan.

ABSTRACT:

Introduction

The aim of this study is to present the results of a multi-institutional outcome analysis conducted to determine the extent of endoscopic Deflux® injection for treating primary vesicoureteral reflux in Japan.

Methods

A 22-question survey was distributed to 174 certified pediatric urologists (Ninteii in Japanese) and councilors of the Japanese Society of Pediatric Urology working at 140 centers to determine the usage and clinical efficacy of Deflux® for treating primary vesicoureteral reflux in Japan.

Results

Forty-three of 140 (30.7%) centers participated, which exceeded participation rates of 27.9 and 18.0% for similar surveys conducted in America in 2006 and 2014, respectively. Deflux® was administered at 43 centers using subureteral transurethral injec

SUBMITTER: Japanese Deflux Injection Therapy Study Group 

PROVIDER: S-EPMC10157820 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature